Hydroquinone Therapeutic Cheat Sheet
Hydroquinone is the most commonly used depigmentation agent and is a first-line treatment for melasma.1Hydroquinone was available previously in over-the-counter products and is currently available in prescription formulations with common concentration ranges of 0.4 to 5%. Prescription strengths available in the United States include hydroquinone 2% and 4% cream and hydroquinone 2% gel.2,3 In Septe …
Hydroquinone is the most commonly used depigmentation agent and is a first-line treatment for melasma.1Hydroquinone was available previously in over-the-counter products and is currently available in prescription formulations with common concentration ranges of 0.4 to 5%. Prescription strengths available in the United States include hydroquinone 2% and 4% cream and hydroquinone 2% gel.2,3 In Septe … 
As 2021 draws to a close, the Journal of Drugs in Dermatology ends the year on a high note! Featuring a strong line up of editorials, original articles, and case reports, the December issue of the JDD includes topics ranging from new treatments for hyperpigmentation, tumescent anesthesia, HS, cosmeceuticals, lower extremity reconstruction, laser hair and identity in transgender men, and everyt … 
At the 2021 Skin of Color Update, Dr. Heather Woolery-Lloyd, Director of the Skin of Color Division at the University of Miami Department of Dermatology, delivered an excellent talk on cosmeceutical recommendations for patients with diverse skin types, a personal favorite subject of hers. Catch the pearls of her talk here!
Hot Topics in Cosmeceuticals
Topical Cannabinoids – The skin has it … 
A patient in my clinic was recently prescribed 5-fluorouracil for severe photodamage, diffuse actinic keratoses. He is 24 years old and, unfortunately, lacked knowledge about photoprotection. It was sobering to think about how much longer he has to live and the damage already done. Strides have been made over the years in educating our patients about photoprotection, but recently, patients have … 
The February issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from acne and depression to "Inflammaging. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Efforts are needed to implement a clinically useful definition of moderate plaque psoriasis in Dermatologists’ Perspectives on Defining Moderate Ps …